Indian Pharmacopoeia Commission seals 3 major MoUs in Nagaland to boost drug safety
New Delhi: In a landmark move poised to strengthen drug safety and public health in the Northeast, the Indian Pharmacopoeia Commission (IPC), Ghaziabad, an autonomous institution under the Ministry of Health and Family Welfare, Government of India, has signed three Memorandum of Understanding (MoU) with Nagaland Medical Council, Nagaland State Drugs Control Administration (NSDCA), Department of Health & Family Welfare, Nagaland and State Pharmacy Council, Government of Nagaland, during the One-Day Training Programme on Pharmacovigilance and Materiovigilance organized by Indian Pharmacopoeia Commission Ghaziabad in collaboration with Nagaland State Drugs Control Administration (NSDCA), Department of Health & Family Welfare, Nagaland.
The programme was aimed at strengthening IPC’s collaborative efforts in promoting public health by facilitating the use of Indian Pharmacopoeia Reference Substances and Impurity Standards in drug testing laboratories under NSDCA, safe and rational use of medicines, enhancing Pharmacovigilance and Materiovigilance activities, and advancing patient safety initiatives across the state of Nagaland.
Through this MoU, IPC is committed to work together with all three organisations, NSDCA and Nagaland State Pharmacy Council and Nagaland Medical Council to strengthen pharmacovigilance and materiovigilance activities, promoting adverse events reporting with use of drugs/medical devices, utilization of the National Formulary of India (NFI) as a standard reference document across healthcare facilities in Nagaland supporting rational dispensing and safe medication practices.
